scholarly article | Q13442814 |
P2093 | author name string | Charles M Rudin | |
Merrill J Egorin | |||
Kevin J Cullen | |||
Lisa M Schumaker | |||
Kenneth Newkirk | |||
Eleanor G Zuhowski | |||
David J VanderWeele | |||
Zejia Yang | |||
P433 | issue | 2 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | cisplatin | Q412415 |
P304 | page(s) | 312-318 | |
P577 | publication date | 2003-01-01 | |
P1433 | published in | Cancer Research | Q326097 |
P1476 | title | Inhibition of glutathione synthesis reverses Bcl-2-mediated cisplatin resistance | |
P478 | volume | 63 |
Q49168230 | Antimicrobial and antiproliferative prospective of kosinostatin - a secondary metabolite isolated from Streptomyces sp. |
Q28478390 | BIM-mediated AKT phosphorylation is a key modulator of arsenic trioxide-induced apoptosis in cisplatin-sensitive and -resistant ovarian cancer cells |
Q37131361 | Buthionine sulfoximine sensitizes antihormone-resistant human breast cancer cells to estrogen-induced apoptosis |
Q51504173 | CHIP buffers heterogeneous Bcl-2 expression levels to prevent augmentation of anticancer drug-resistant cell population. |
Q38782479 | Curcumin downregulates p38 MAPK-dependent X-ray repair cross-complement group 1 (XRCC1) expression to enhance cisplatin-induced cytotoxicity in human lung cancer cells |
Q35751980 | Curcumin induces G2/M arrest and apoptosis in cisplatin-resistant human ovarian cancer cells by modulating Akt and p38 MAPK |
Q46909405 | Decreased glutathione levels potentiate the apoptotic efficacy of selenium: possible involvement of p38 and JNK MAPKs--in vitro studies |
Q34619471 | Different apoptotic effects of [Pt(O,O'-acac)(γ-acac)(DMS)] and cisplatin on normal and cancerous human epithelial breast cells in primary culture |
Q36123399 | Divergent effects of compounds on the hydrolysis and transpeptidation reactions of γ-glutamyl transpeptidase |
Q34038268 | Downregulation of cystine transporter xc by irinotecan in human head and neck cancer FaDu xenografts |
Q28469051 | Dysfunctional KEAP1-NRF2 interaction in non-small-cell lung cancer |
Q40603990 | Effect of NF-kappaB, survivin, Bcl-2 and Caspase3 on apoptosis of gastric cancer cells induced by tumor necrosis factor related apoptosis inducing ligand. |
Q36069093 | Electron transfer-based combination therapy of cisplatin with tetramethyl-p-phenylenediamine for ovarian, cervical, and lung cancers. |
Q35269285 | Enhancement of carboplatin-mediated lung cancer cell killing by simultaneous disruption of glutathione and thioredoxin metabolism. |
Q35858428 | Evaluation of cloned cells, animal model, and ATRA sensitivity of human testicular yolk sac tumor |
Q55261457 | Exogenous glutathione contributes to cisplatin resistance in lung cancer A549 cells. |
Q37698424 | Flavonoid-induced glutathione depletion: potential implications for cancer treatment |
Q64064084 | Functional and transcriptomic characterization of carboplatin-resistant A2780 ovarian cancer cell line |
Q35045640 | Gene expression in Barrett's esophagus and reflux esophagitis induced by gastroduodenoesophageal reflux in rats |
Q36291188 | Glutathione depletion sensitizes cisplatin- and temozolomide-resistant glioma cells in vitro and in vivo |
Q36326528 | Glutathione efflux and cell death |
Q36316764 | Harnessing drug resistance: using ABC transporter proteins to target cancer cells |
Q36786878 | Influence of limonin on Wnt signalling molecule in HepG2 cell lines |
Q37342850 | Inhibition of p38 MAPK sensitizes tumour cells to cisplatin-induced apoptosis mediated by reactive oxygen species and JNK. |
Q36763234 | Interaction between glutathione and apoptosis in systemic lupus erythematosus |
Q42875767 | Interfering with ROS Metabolism in Cancer Cells: The Potential Role of Quercetin. |
Q93119363 | Intracellular catalase activity instead of glutathione level dominates the resistance of cells to reactive oxygen species |
Q35119851 | Intratumoral decorin gene delivery by AAV vector inhibits brain glioblastomas and prolongs survival of animals by inducing cell differentiation |
Q33554403 | MRP2 and GSTP1 polymorphisms and chemotherapy response in advanced non-small cell lung cancer |
Q90678045 | Manipulation of Glucose and Hydroperoxide Metabolism to Improve Radiation Response |
Q36743607 | Mitochondria as a critical target of the chemotheraputic agent cisplatin in head and neck cancer. |
Q35758048 | Molecular mechanisms of resistance and toxicity associated with platinating agents |
Q36495493 | NCX-4040, a nitric oxide-releasing aspirin, sensitizes drug-resistant human ovarian xenograft tumors to cisplatin by depletion of cellular thiols |
Q61958115 | Nicotinamide Nucleotide Transhydrogenase as a Novel Treatment Target in Adrenocortical Carcinoma |
Q36669884 | Overexpression of Bcl-2 as a proxy redox stimulus to enhance activity of non-viral redox-responsive delivery vectors |
Q33847525 | Potential of l-buthionine sulfoximine to enhance the apoptotic action of estradiol to reverse acquired antihormonal resistance in metastatic breast cancer |
Q33894596 | Potential use of the anti-inflammatory drug, sulfasalazine, for targeted therapy of pancreatic cancer. |
Q39108554 | Preclinical high-dose acetaminophen with N-acetylcysteine rescue enhances the efficacy of cisplatin chemotherapy in atypical teratoid rhabdoid tumors |
Q35643843 | Proapoptotic protein Smac mediates apoptosis in cisplatin-resistant ovarian cancer cells when treated with the anti-tumor agent AT101. |
Q37281667 | Prolactin confers resistance against cisplatin in breast cancer cells by activating glutathione-S-transferase |
Q43659868 | Protective effects of ascorbic acid on behavior and oxidative status of restraint-stressed mice |
Q28484976 | Purine nucleoside analog--sulfinosine modulates diverse mechanisms of cancer progression in multi-drug resistant cancer cell lines |
Q36038217 | Redox mechanisms of cytoprotection by Bcl-2. |
Q34362281 | Scientific rationale for postmenopause delay in the use of conjugated equine estrogens among postmenopausal women that causes reduction in breast cancer incidence and mortality |
Q37698436 | Selected flavonoids potentiate the toxicity of cisplatin in human lung adenocarcinoma cells: a role for glutathione depletion |
Q34989086 | Synergistic apoptosis of CML cells by buthionine sulfoximine and hydroxychavicol correlates with activation of AIF and GSH-ROS-JNK-ERK-iNOS pathway |
Q36502644 | The effects of buthionine sulfoximine on the proliferation and apoptosis of biliary tract cancer cells induced by cisplatin and gemcitabine |
Q38713186 | The role of oxidative stress on breast cancer development and therapy. |
Q36525103 | ZNF143 transcription factor mediates cell survival through upregulation of the GPX1 activity in the mitochondrial respiratory dysfunction |
Q36381494 | [Pt(O,O'-acac)(gamma-acac)(DMS)], a new Pt compound exerting fast cytotoxicity in MCF-7 breast cancer cells via the mitochondrial apoptotic pathway |
Search more.